Other critical genetic changes include 1p loss of heterozygosity, commonly associated with unresectable metastatic disease and MYCN amplification, and 11q deletion, which correlates with advanced disease stages and poor survival (30–32). Here, MYCN is linked to metastatic neoplasm.